SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003706
Filing Date
2015-05-08
Accepted
2015-05-08 13:43:14
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clvs-10q_20150331.htm 10-Q 1207596
2 EX-31.1 clvs-ex311_201503316.htm EX-31.1 12646
3 EX-31.2 clvs-ex312_201503317.htm EX-31.2 12523
4 EX-32.1 clvs-ex321_201503318.htm EX-32.1 4158
5 EX-32.2 clvs-ex322_201503319.htm EX-32.2 4284
  Complete submission text file 0001564590-15-003706.txt   6732010

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT clvs-20150331.xml EX-101.INS 1084723
7 XBRL TAXONOMY EXTENSION SCHEMA clvs-20150331.xsd EX-101.SCH 40450
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clvs-20150331_cal.xml EX-101.CAL 39574
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clvs-20150331_def.xml EX-101.DEF 95421
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE clvs-20150331_lab.xml EX-101.LAB 309764
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clvs-20150331_pre.xml EX-101.PRE 229557
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35347 | Film No.: 15845684
SIC: 2834 Pharmaceutical Preparations